Screener
Avalo Therapeutics AVTX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Net loss | $(36,358) | $(20,765) | $(55,988) | $(33,914) |
| Net loss per share of common stock, basic and diluted | $(0.83) | $(1.92) | $(1.75) | $(3.18) |
| Weighted average common shares outstanding | 43,602,044 | 10,829,760 | 31,919,388 | 10,673,200 |
| Comprehensive loss: | ||||
| Net loss | $(36,358) | $(20,765) | $(55,988) | $(33,914) |
| Other comprehensive loss: | ||||
| Unrealized loss on investments, net | (577) | (34) | (651) | (34) |
| Comprehensive loss | $(36,935) | $(20,799) | $(56,639) | $(33,948) |
Item 1. Financial Statements.
FAQ
- What is Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Avalo Therapeutics (AVTX) reported comprehensive income (loss), net of tax, attributable to parent of -$36.94M in Q2 2026.
- How has Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 77.6% year-over-year, from -$20.8M to -$36.94M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- The total change in equity during the period resulting from transactions and other events from non-owner sources, including net income and other comprehensive income items. This provides a holistic view of the company's financial health by incorporating both operational results and unrealized gains or losses. It serves as a comprehensive measure of the total change in the company's net worth over the reporting period.
Ask your AI about Avalo Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude